Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Harvard Business School
US Department of Justice
AstraZeneca
Dow
Teva
Farmers Insurance
Merck
Healthtrust
Mallinckrodt

Generated: January 23, 2018

DrugPatentWatch Database Preview

NYSTATIN Drug Profile

« Back to Dashboard

Which patents cover Nystatin, and what generic alternatives are available?

Nystatin is a drug marketed by Actavis Mid Atlantic, Crown Labs Inc, Fougera Pharms, G And W Labs Inc, Perrigo New York, Taro, Vintage, Paddock Llc, Gavis Pharms, Lyne, Mayne Pharma Inc, Nesher Pharms, Upsher-smith Labs, X Gen Pharms, Allied Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, Hi Tech Pharma, Morton Grove, Pharm Assoc, Pharmaderm, Pharmafair, Taro Pharm, Teva, Vintage Pharms, Vistapharm, Wockhardt, Heritage Pharms Inc, Quantum Pharmics, Sandoz, Sun Pharm Industries, Usl Pharma, Watson Labs, Fougera, Odyssey Pharms, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Perrigo Uk Finco, Akorn, Riconpharma Llc, and Teligent Pharma Inc. and is included in seventy-one NDAs.

The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Drug patent expirations by year for NYSTATIN
Pharmacology for NYSTATIN
Ingredient-typePolyenes
Drug ClassPolyene Antifungal

US Patents and Regulatory Information for NYSTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva NYSTATIN nystatin TABLET;ORAL 062506-001 Jan 16, 1984 AA RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NYSTATIN nystatin SUSPENSION;ORAL 062670-001 Jun 18, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva NYSTATIN nystatin TABLET;VAGINAL 062502-001 Dec 23, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Akorn NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 207217-001 Aug 4, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Odyssey Pharms NYSTATIN nystatin TABLET;VAGINAL 062615-001 Oct 17, 1985 RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs NYSTATIN nystatin TABLET;VAGINAL 062176-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo New York NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 062186-002 Jun 6, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 207741-001 Jan 31, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharm Assoc NYSTATIN nystatin SUSPENSION;ORAL 203621-001 Jan 7, 2016 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vintage Pharms NYSTATIN nystatin SUSPENSION;ORAL 065148-001 Jun 28, 2005 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Federal Trade Commission
Merck
Covington
Dow
Daiichi Sankyo
Healthtrust
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot